Schrödinger is a hybrid biopharma company specializing in physics-based computational chemistry and traditional drug development. The company aims to utilize computational methods to create better ...

AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...

Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...

The numbers in drug discovery are daunting. Identifying a molecule with therapeutic promise and advancing it through preclinical and clinical development can take more than a decade at costs topping ...

Picture a world where our genomes are sequenced at birth, genetic errors corrected, and continuous monitoring of vital signs allows for tailored dietary and lifestyle adjustments to preempt diseases.

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

"The future is already here—it's just not evenly distributed," Maulik Mukeshbhai Patel, a seasoned biopharmaceutical expert, remarked at a recent industry conference. His statement captures the ...

Alex Zhavoronkov believes we’re cusp of what he calls “pharmaceutical superintelligence.” Courtesy of Insilico Medicine Zhavoronkov believes the industry is on the cusp of what he calls ...

Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...